Aisling Capital Management LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma Inc. (BBIO)(BBIO) | 6,068,125 | 6,089,611 | +21,486 | 262,021,638 | 316,294,395 | 69.29% | +54,272,757 |
| Syndax Pharmaceuticals, Inc. (SNDX)(SNDX) | 1,316,806 | 1,316,806 | 0 | 12,325,304 | 20,265,644 | 4.44% | +7,940,340 |
| Verona Pharma plc (VRNA) | 615,352 | 615,352 | 0 | 58,199,992 | 65,664,212 | 14.39% | +7,464,220 |
| BridgeBio Oncology Therapeutics (BBOT) | 0 | 564,625 | +564,625 | 0 | 6,538,358 | 1.43% | +6,538,358 |
| Nuvation Bio Inc. (NUVB)(NUVB) | 2,541,009 | 2,960,659 | +419,650 | 4,954,968 | 10,954,438 | 2.40% | +5,999,470 |
| Monte Rosa Therapeutics Inc (GLUE)(GLUE) | 1,472,331 | 1,472,331 | 0 | 6,640,213 | 10,909,973 | 2.39% | +4,269,760 |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | 5,285,258 | 8,983,231 | 1.97% | +3,697,973 |
| Compass Pathways Plc (CMPS)(CMPS) | 1,198,418 | 1,198,418 | 0 | 3,355,570 | 6,866,935 | 1.50% | +3,511,365 |
| Scholar Rock Holding Corporation (SRRK)(SRRK) | 0 | 77,031 | +77,031 | 0 | 2,868,634 | 0.63% | +2,868,634 |
| CalciMedica, Inc. (CALC) | 521,114 | 521,114 | 0 | 833,782 | 1,602,842 | 0.35% | +769,060 |
| Biomea Fusion Inc (BMEA) | 2,048,757 | 2,048,757 | 0 | 3,687,763 | 4,138,489 | 0.91% | +450,726 |
| Aclaris Therapeutics Inc (ACRS) | 434,455 | 434,455 | 0 | 616,926 | 825,465 | 0.18% | +208,539 |
| OnKure Therapeutics, Inc. (OKUR) | 88,607 | 88,607 | 0 | 211,771 | 243,669 | 0.05% | +31,898 |
| Marker Therapeutics, Inc. (MRKR) | 325,370 | 325,370 | 0 | 497,816 | 290,425 | 0.06% | -207,391 |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 0 | -2,834,910 | 1,040,695 | 0 | — | -1,040,695 |